Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer 2023-06-05 21:26
RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name 2023-06-05 21:17
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure 2023-06-05 21:00
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing 2023-06-05 20:00
Prenetics Announces First Quarter 2023 Financial Results 2023-06-05 19:20
Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study for Medical Aesthetics Treatment in Adults Undergoing Abdominoplasty 2023-06-05 19:12
Live from ASCO 2023 | For the Third Consecutive Year, Ascentage Pharma Releases Promising Results of Alrizomadlin plus Pembrolizumab in Patients with Cutaneous Melanoma that Failed Immuno-Oncologic (IO) Therapies 2023-06-05 17:34
Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage with AI-Powered Mammography Analysis 2023-06-05 15:00
Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX 2023-06-05 14:37
American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian 2023-06-05 12:30
Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough 2023-06-05 11:51
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020 2023-06-05 09:01
VVN539 met primary study endpoints in US phase IIa clinical study for the treatment of glaucoma 2023-06-05 08:00
Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting 2023-06-05 08:00
Sanyou launches new European offices and continues to promote global business landscape 2023-06-03 20:05
Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST 2023-06-03 07:59
Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference. 2023-06-02 19:14
Latest Updates of 9 Viva's Portfolio Companies 2023-06-02 18:51
TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA) 2023-06-02 15:51
NMPA accepted Akeso's ebronucimab (PCSK9) marketing application in two cardiovascular indications 2023-06-02 11:43
1 99 100 101 102 103 413